Is ceritinib/ceritinib included in medical insurance?
Ceritinib/Ceritinib is a targeted therapy for ALK (tyrosine kinase) fusion-positive non-small cell lung cancer (NSCLC). Ceritinib is an important treatment option for patients with ALKfusion-positive NSCLC. In clinical trials and practice, Ceritinib has shown significant efficacy, bringing hope to patients with this specific subtype of lung cancer. Ceritinib/Ceritinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically, but the price is high. Please consult your local pharmacy for details. Foreign original drugs are divided into original drugs and generic drugs. Foreign original drugs are mainly Swiss Novartis original drugs. Specification150mg*150The price is about13,500 yuan. Generic drugs mainly include Bangladeshi version, with specifications of 150mg*30 and the price is around 1,300 yuan. The ingredients of original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)